stars 1 stars 2 stars 3

With state of the art wet lab and animal facility in Vancouver, British Columbia, PharmaPlanter Technologies Inc. provides one-stop biomodeling solution and CRO services under the brand of Therapeutic Modeling & Experimentation (TME). We turn our expertise in mouse and cell line modeling into an efficient and cost-effective technology platform and provide contract research services, mainly focusing on preclinical studies and IND-enabling services, to assist biotech companies to develop their therapeutic solutions and to support life science researchers to translate their scientific work into future therapies, aiming to overcome critical health challenges. Our areas of expertise include - • Gene engineering animal and cell models • Monoclonal antibody development • Animal experimentation • Culture media To learn more details, please visit TME website https://www.tme-scientific.com

PharmaPlanter Technologies Questions

The PharmaPlanter Technologies annual revenue was $2 million in 2026.

Hongwei Cheng is the CEO of PharmaPlanter Technologies.

6 people are employed at PharmaPlanter Technologies.

PharmaPlanter Technologies is based in Burnaby, British Columbia.

The NAICS codes for PharmaPlanter Technologies are [325, 32].

The SIC codes for PharmaPlanter Technologies are [283, 28].

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users